Keveyis is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Xeris Pharmaceuticals, Inc.. The primary component is Dichlorphenamide.
| Product ID | 72065-001_d30a8795-39d2-51c3-e053-2995a90abcf0 |
| NDC | 72065-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Keveyis |
| Generic Name | Dichlorphenamide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-12-13 |
| Marketing Category | NDA / |
| Application Number | NDA011366 |
| Labeler Name | Xeris Pharmaceuticals, Inc. |
| Substance Name | DICHLORPHENAMIDE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [CS],Carbonic Anhydrase Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-12-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 51672-4177 | Keveyis | Dichlorphenamide |
| 71090-001 | Keveyis | Dichlorphenamide |
| 72065-001 | Keveyis | Dichlorphenamide |
| 51672-4144 | DARANIDE | dichlorphenamide |
| 13668-676 | Dichlorphenamide | Dichlorphenamide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() KEVEYIS 86724075 5034655 Live/Registered |
TARO PHARMACEUTICALS U.S.A., INC. 2015-08-13 |